These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3073067)

  • 1. Combined effect of exercise and ambient temperature on insulin absorption and postprandial glycemia in type I patients.
    Rönnemaa T; Koivisto VA
    Diabetes Care; 1988; 11(10):769-73. PubMed ID: 3073067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial blood glucose response to exercise in type I diabetes: comparison between pump and injection therapy.
    Koivisto VA; Tronier B
    Diabetes Care; 1983; 6(5):436-40. PubMed ID: 6400702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone response of diabetic patients to exercise at cool and warm temperatures.
    Rönnemaa T; Marniemi J; Leino A; Karanko H; Puukka P; Koivisto VA
    Eur J Appl Physiol Occup Physiol; 1991; 62(2):109-15. PubMed ID: 2022198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial exercise in type I diabetic patients on multiple daily insulin injection regimen.
    Trovati M; Anfossi G; Vitali S; Mularoni E; Massucco P; De Facis R; Carta Q; Lucchina PG; Emanuelli G
    Diabetes Care; 1988 Feb; 11(2):107-10. PubMed ID: 3289860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.
    Bantle JP; Neal L; Frankamp LM
    Diabetes Care; 1993 Dec; 16(12):1592-7. PubMed ID: 8299455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accommodating planned exercise in type I diabetic patients on intensive treatment.
    Schiffrin A; Parikh S
    Diabetes Care; 1985; 8(4):337-42. PubMed ID: 3899554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro).
    Rabasa-Lhoret R; Bourque J; Ducros F; Chiasson JL
    Diabetes Care; 2001 Apr; 24(4):625-30. PubMed ID: 11315820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meal composition is a determinant of lispro-induced hypoglycemia in IDDM.
    Burge MR; Castillo KR; Schade DS
    Diabetes Care; 1997 Feb; 20(2):152-5. PubMed ID: 9118763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing insulin therapy during exercise in type 1 diabetes mellitus.
    Toni S; Reali MF; Barni F; Lenzi L; Festini F
    Acta Biomed; 2006; 77 Suppl 1():34-40. PubMed ID: 16918069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus.
    Spinas GA; Bock A; Keller U
    Diabetes Care; 1985; 8(5):429-35. PubMed ID: 2865093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
    de Meijer PH; Lutterman JA
    Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved insulin absorption by means of standardized injection site modulation results in a safer and more efficient prandial insulin treatment. A review of the existing clinical data.
    Pfützner A; Raz I; Bitton G; Klonoff D; Nagar R; Hermanns N; Haak T
    J Diabetes Sci Technol; 2015 Jan; 9(1):116-22. PubMed ID: 25352633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies.
    Olsson PO
    Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The absorption of short-acting insulin administered subcutaneously in diabetic patients].
    Nakamura T; Sekino K; Kasai F; Ishii F; Kudoo M; Imamura K; Kikuchi N; Takebe K
    Probl Endokrinol (Mosk); 1993; 39(2):14-6. PubMed ID: 8016042
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus.
    Perriello G; Torlone E; Di Santo S; Fanelli C; De Feo P; Santeusanio F; Brunetti P; Bolli GB
    Diabetologia; 1988 Nov; 31(11):811-5. PubMed ID: 3069528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.